A. Essaian

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

Medicine, Endocrinology, Nephrology +10

A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis

Brad H. Rovin, Neil Solomons, William F. Pendergraft et al. · Kidney International · 2018 · 304 citations

Medicine, Nephrology, Pharmacology +8

A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients

Sunil Bhandari, Philip A. Kalra, Jatin Kothari et al. · Nephrology Dialysis Transplantation · 2015 · 78 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Rehabilitation after COVID-19. Resolution of the International Expert Council of the Eurasian Association of Therapists and the Russian Society of Cardiology

A. G. Arutyunov, Petar Seferović, Goran Krstačić et al. · Russian Journal of Cardiology · 2021 · 16 citations · Full text

Medicine, Health Sciences, Rehabilitation Medicine +5

Epoetin theta: efficacy and safety of subcutaneous administration in anemic pre-dialysis patients in the maintenance phase in comparison to epoetin beta

Beate Gertz, P. Kes, A. Essaian et al. · Current Medical Research and Opinion · 2012 · 12 citations

Medicine, Pharmacology, Pharmacotherapy +17